SCHEMBL9883262

SCHEMBL9883262

CCCC(=O)C(CC)CC

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
FFAR3 O14843 3/20 0.43
HDAC3 O15379 3/20 0.43
HDAC1 Q13547 3/20 0.43
HDAC2 Q92769 3/20 0.43
HDAC8 Q9BY41 3/20 0.43
CA2 P00918 3/20 0.42
MAPK1 P28482 1/20 0.42
TSHR P16473 2/20 0.41
CA1 P00915 1/20 0.41
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2465225 0.92 CES2 (0.39) CES2CES1FFAR3HDAC3HDAC1
SCHEMBL328134 0.88 USP2 (0.43) CA2MAPK1TSHRCA1USP2
SCHEMBL20838325 0.87 HDAC1 (0.50) CES2CES1FFAR3HDAC3HDAC1
SCHEMBL8860533 0.86 CES2 (0.43) CES2CES1FFAR3HDAC3HDAC1
SCHEMBL11600930 0.85 CES2 (0.38) CES2CES1FFAR3HDAC3HDAC1
SCHEMBL28240119 0.85 CES2 (0.38) CES2CES1FFAR3HDAC3HDAC1
SCHEMBL11575753 0.83 CA2 (0.50) CES2CES1CA2MAPK1CA1
SCHEMBL21343979 0.83 SLC1A3 (0.38) CES2CES1FFAR3HDAC3HDAC1
SCHEMBL812448 0.83 CA2 (0.61) CA2MAPK1CA1
SCHEMBL28747829 0.83 CA2 (0.40) CES2CES1FFAR3HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112424154-B Process for producing ketone mixture 捷恩智株式会社 2024-01-09 CN claimed
US-10990013-B2 Method for forming semiconductor structure TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2021-04-27 US claimed
CN-112424154-A Process for producing ketone 捷恩智株式会社 2021-02-26 CN claimed
WO-2020017135-A1 METHOD FOR MANUFACTURING KETONES JNC株式会社 2020-01-23 WO claimed
US-12222653-B2 Method for forming semiconductor structure TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2025-02-11 US disclosed
US-20240092973-A1 POLYIMIDE PRECURSOR, RESIN COMPOSITION, PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR MANUFACTURING PATTERNED CURED FILM, CURED FILM, INTERLAYER INSULATING FILM, COVER COAT LAYER, SURFACE-PROTECTIVE FILM, AND ELECTRONIC COMPONENT HD MICROSYSTEMS, LTD. (JP) 2024-03-21 US disclosed
CN-112424154-B Process for producing ketone mixture 捷恩智株式会社 2024-01-09 CN disclosed
US-20210286269-A1 METHOD FOR FORMING SEMICONDUCTOR STRUCTURE TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2021-09-16 US disclosed
US-11009796-B2 Method for forming semiconductor structure TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2021-05-18 US disclosed
US-11009796-B2 Method for forming semiconductor structure TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2021-05-18 US disclosed
US-10990013-B2 Method for forming semiconductor structure TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2021-04-27 US disclosed
US-10990013-B2 Method for forming semiconductor structure TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2021-04-27 US disclosed
US-9482787-B2 Polymerizable composition MITSUI CHEMICALS, INC. (JP) 2016-11-01 US disclosed
US-20140245658-A1 SYNTHESIS OF ETHANOL AND HIGHER ALCOHOLS BY HYDROGENATION OF KETENE PIONEER ENERGY INC (US) 2014-09-04 US disclosed
EP-2725045-A1 POLYMERIZABLE COMPOSITION Mitsui Chemicals, Inc. (JP) 2014-04-30 EP disclosed
US-20120136049-A1 ANTIBACTERIAL AGENT OSAKA UNIVERSITY (JP) 2012-05-31 US disclosed
US-7314960-B1 Catalytic synthesis of oxygenate from alcohol YUAN ZE UNIVERSITY (TW) 2008-01-01 US disclosed
US-7314960-B1 Catalytic synthesis of oxygenate from alcohol YUAN ZE UNIVERSITY (TW) 2008-01-01 US disclosed
EP-0004335-A2 Prostacyclin analogs, process and intermediates for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1979-10-03 EP disclosed
EP-0001270-A1 Analogues of prostacycline, methods for their preparation and their use in the treatment of circulatory diseases HOECHST AKTIENGESELLSCHAFT (DE) 1979-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140245658-A1 SYNTHESIS OF ETHANOL AND HIGHER ALCOHOLS BY HYDROGENATION OF KETENE ADH1A, GK, ADH1C CES2 1053/4885CES1 1814/4885FFAR3 143/4885
US-20120136049-A1 ANTIBACTERIAL AGENT TEAD4, ELOVL6, TEAD1 CES2 3717/4885CES1 2878/4885FFAR3 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.